期刊文献+

胰岛素抵抗和非胰岛素抵抗多囊卵巢综合征患者的对比研究 被引量:8

Comparative Study of Polycystic Ovary Syndrome with and without Insulin Resistance
下载PDF
导出
摘要 目的探讨多囊卵巢综合征(PCOS)胰岛素抵抗(IR)患者的临床特征。方法选取48例PCOS患者,将稳态模型胰岛素抵抗指数(HOMA-IR)>3.8或葡萄糖及胰岛素曲线下面积比值(AUC葡萄糖/AUC胰岛素)<1.0的PCOS患者作为IR组(30例),上述两个标准均不符合的PCOS患者作为非IR组(18例)。比较IR组和非IR组患者的体质指数(BMI)、血脂水平及各项性激素水平。结果 (1)IR组患者BMI及肥胖者所占比例均显著高于非IR组,差异有统计学意义(P<0.05);(2)IR组患者三酰甘油、载脂蛋白B水平均显著高于非IR组,而高密度脂蛋白、载脂蛋白AⅠ水平则显著低于非IR组,差异均有统计学意义(P<0.05);(3)IR组患者黄体生成素水平显著低于非IR组,睾酮水平则显著高于非IR组,差异亦有统计学意义(P<0.05)。结论 (1)存在IR的PCOS患者更容易出现血脂异常;(2)PCOS患者性激素有不同改变,存在IR者以睾酮升高为主而非IR患者则以黄体生成素升高为主。 Objective To investigate the clinical characteristics of polycystic ovary syndrome(PCOS) patients with insulin resistance.Methods Retrospective analysis is carried out in 48 PCOS patients.The insulin resistant group included 30 PCOS patients with homeostasis model assessment of insulin resistance(HOMA-IR) above 3.8 or insulin to glucose ratio of area under curve(AUCG/AUCI) below 1.0.The non-insulin resistant group was composed of 18 PCOS patients that met neither of the above two standards.Body mass index(BMI),sex hormone levels,and lipid levels of the two groups were compared.Results The body mass index(BMI) and proportion of obese subjects were higher in the insulin resistant group than in the non-insulin resistant group,with significant difference between the two groups(P0.05).Levels of triglyceride(TG) and Apolipoprotein B(ApoB) were higher,while levels of high density lipoprotein(HDL) and Apolipoprotein AⅠ(Apo AⅠ) were lower in the insulin resistant group than in the non-insulin resistant group,with significant difference between the two groups(P0.05).Level of luteinizing hormone(LH) was lower,while level of Testosterone(T) was higher in the insulin resistant group than in the non-insulin resistant group,with significant difference between the two groups(P0.05).Conclusion PCOS patients with insulin resistance are more likely to suffer from lipid abnormalities.Remarkable difference exists in the levels of sex hormone between PCOS patients with or without insulin resistance,with testosterone levels elevated in the insulin resistant group,while luteinizing hormone levels elevated in the non-insulin resistant group.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第32期3699-3701,共3页 Chinese General Practice
基金 新疆维吾尔自治区重点学科(内科学)建设经费(2004-2008)
关键词 多囊卵巢综合征 胰岛素抵抗 血脂异常 性腺甾类激素 Polycystic ovary syndrome Insulin resistance Dyslipidemias Gonadal steroid hormones
  • 相关文献

参考文献17

  • 1Azgig B. Polycystlc ovary syndrome, insulin resistance, and molecular defects of insulin signaling EJ]. J Clin Endocrinol Metal), 2002, 87(9) : 4085 -4087.
  • 2The Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related ~ polycystic ovary syndrome [ J]. Fertility and Ste- rility, 2004, 81 (1): 19 -25.
  • 3李旻,邱红玉,孙永玉,李红发.体重指数正常的多囊卵巢综合征与胰岛素抵抗[J].华中科技大学学报(医学版),2004,33(1):58-61. 被引量:6
  • 4杨冬梓,陈晓莉.PCOS胰岛素抵抗的检测和评估[J].实用妇产科杂志,2005,21(9):515-517. 被引量:8
  • 5姚元庆,陈春玲.多囊卵巢综合征的胰岛素抵抗[J].中国实用妇科与产科杂志,2002,18(11):645-647. 被引量:19
  • 6Otto C, Otto B, Coke B, et al. Increase in adiponecfin levels during pioglitazone therapy in relation to glucose control, insulin resistanee as well as ghrelin and resist in levels [ J ]. J Endocrinal Invest, 2006, 29(3) : 231 -236.
  • 7郑俊,滕香宇,刘伟.噻唑烷二酮类药物改善多囊卵巢综合征患者胰岛素抵抗的作用[J].中国全科医学,2009,12(20):1920-1922. 被引量:22
  • 8Caro J. Cellular alteration in liver, skeletal muscle and adipotissue re- sponsible for insulin resistance in obesity and type 2 diabetes [ J]. Dia- betes Metab Rev, 1989, 5: 655.
  • 9吴效科,张祖暄,苏延华.多囊卵巢综合征患者脂代谢的研究[J].中华妇产科杂志,1998,33(1):25-27. 被引量:10
  • 10WaUdius G, Jungner I, Aastveit AH, et al. The apoB/apoA- I ra- tio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and atiatherogenic lipopmteins and to predict cor- onary risk [J]. Clin (]hem Lab Med, 2004, 42: 1355.

二级参考文献37

  • 1林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688. 被引量:74
  • 2马毅,吴效科.胰岛素抵抗在妊娠期糖尿病与多囊卵巢综合征发病中的作用[J].中国全科医学,2006,9(24):2082-2084. 被引量:5
  • 3金惠玲,郭如雅.多囊卵巢综合征干预治疗的临床研究(附76例报告)[J].中国医师杂志,2007,9(6):803-804. 被引量:6
  • 4Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis [ J ]. Endocr Rev, 1997, 18 (6) : 774 -800.
  • 5Rautio K, Tapanainen JS, Ruokonen A, et al. Endocrine and metabolic effects of ros- iglitazone in overweight women with PCOS: a randomized placebo - controlled study [ J ]. Human Reproduction, 2006, 21 (6): 1400 - 1407.
  • 6Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus [ J ]. Fertil Steril, 2002, 77 (6) : 1095 - 1105.
  • 7Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystie ovary syndrome in an unselected population [ J ]. Clin Endocrinol Metab, 2004, 89 (6): 2745 - 2749.
  • 8Qin KN, Rosenfield RL. Role of cytochrone P450c17 in polycystic ovary syndrome [J]. J Mol Cell Endocrinol, 1998, 145 (1): 111 -121.
  • 9Frank S. Polycystic ovary syndrome [ J ]. N Engl J Mad, 1995, 333 (13) : 853 -856.
  • 10Kuscu NK, Koyuncu F, Ozbilgin K, et al. Insulin: does it induce follicular arrest in the rat ovary? [J]. Gynecol Endoerinol, 2002, 16 (5): 361-364.

共引文献75

同被引文献69

引证文献8

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部